Literature DB >> 15140758

High concentration of glucose inhibits glomerular endothelial eNOS through a PKC mechanism.

Shaoyou Chu1, H Glenn Bohlen.   

Abstract

Kidney glomeruli are important targets of diabetic nephropathy. We hypothesized a high concentration of glucose could suppress glomerular endothelial nitric oxide synthase (eNOS) by a protein kinase C (PKC) mechanism, as has been found in other tissues. Mouse kidney slices (150-200 microm) were bathed in Hanks' solution with 100 microM L-arginine and exposed to either 5 or 20-30 mM D-glucose. Immunofluorescence identified only eNOS in normal mouse glomeruli. Measurements of glomerular NO concentration with NO-sensitive fluorescent dye (4,5-diaminofluorescein diacetate) using confocal microscopy and NO-sensitive microelectrodes verified that resting glomeruli had active production of NO that was inhibited by N(G)-nitro-L-arginine methyl ester. High-concentration (20-30 mM) D-glucose inhibited 60-70% of the NO production within 15-30 min; L-glucose at the same concentration did not have any effect. Inhibition of PKC-beta with 100 nM ruboxistaurin prevented eNOS suppression in high-glucose media. Activation of PKC with 100 nM phorbol ester also suppressed the glomerular NO concentration. We concluded that eNOS in the renal glomerular capillary endothelial cells is suppressed by activity of PKC at high-glucose concentrations comparable to those in diabetic animals and humans. The consequence is a rapid decline in the generation of NO in the glomerular endothelial cells in the presence of a high concentration of glucose.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15140758     DOI: 10.1152/ajprenal.00006.2004

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  17 in total

1.  Periadventitial adipose tissue impairs coronary endothelial function via PKC-beta-dependent phosphorylation of nitric oxide synthase.

Authors:  Gregory A Payne; H Glenn Bohlen; U Deniz Dincer; Léna Borbouse; Johnathan D Tune
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-29       Impact factor: 4.733

2.  Transfer of nitric oxide by blood from upstream to downstream resistance vessels causes microvascular dilation.

Authors:  H G Bohlen; X Zhou; J L Unthank; S J Miller; R Bills
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-07       Impact factor: 4.733

Review 3.  New potential agents in treating diabetic kidney disease: the fourth act.

Authors:  Mark E Williams
Journal:  Drugs       Date:  2006       Impact factor: 9.546

4.  Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non-insulin-dependent Otsuka Long-Evans Tokushima Fatty rats.

Authors:  Yoshihiro Kuno; Masayuki Iyoda; Takanori Shibata; Yuki Hirai; Tadao Akizawa
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

Review 5.  Pathogenic role of nitric oxide alterations in diabetic nephropathy.

Authors:  Sharma S Prabhakar
Journal:  Curr Diab Rep       Date:  2005-12       Impact factor: 4.810

6.  Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy.

Authors:  Paolo Tessari; Diego Cecchet; Alessandra Cosma; Monica Vettore; Anna Coracina; Renato Millioni; Elisabetta Iori; Lucia Puricelli; Angelo Avogaro; Monica Vedovato
Journal:  Diabetes       Date:  2010-05-18       Impact factor: 9.461

7.  Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice.

Authors:  Yukiko Kanetsuna; Keiko Takahashi; Michio Nagata; Maureen A Gannon; Matthew D Breyer; Raymond C Harris; Takamune Takahashi
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

8.  NAD(P)H oxidase-derived peroxide mediates elevated basal and impaired flow-induced NO production in SHR mesenteric arteries in vivo.

Authors:  Xiaosun Zhou; H Glenn Bohlen; Steven J Miller; Joseph L Unthank
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-03       Impact factor: 4.733

Review 9.  Nitric oxide in the normal kidney and in patients with diabetic nephropathy.

Authors:  Paolo Tessari
Journal:  J Nephrol       Date:  2014-09-13       Impact factor: 3.902

10.  Extracellular arginine rapidly dilates in vivo intestinal arteries and arterioles through a nitric oxide mechanism.

Authors:  Laura Pezzuto; H Glenn Bohlen
Journal:  Microcirculation       Date:  2008-02       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.